Publisher
Springer Science and Business Media LLC
Subject
Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine
Reference18 articles.
1. Joharatnam-Hogan N, Chambers P, Dhatariya K, Board R; the Joint British Diabetes Society for Inpatient Care (JBDS), UK Chemotherapy Board (UKCB) (2022) A guideline for the outpatient management of glycaemic control in people with cancer. Diabet Med 39:e14636
2. Jing L, Ni-ya N, Qun-xian R et al (2017) Pretreatment glycemic control status is an independent prognostic factor for cervical cancer patients receiving neoadjuvant chemotherapy for locally advanced disease. BMC Cancer 17:517
3. Nik-Ahd F, Howard LE, Eisenberg AT et al (2019) Poorly controlled diabetes increases the risk of metastases and castration-resistant prostate cancer in men undergoing radical prostatectomy: results from the search database. Cancer 125:2861–2867
4. Shariff AI, Syed S, Shelby RA et al (2019) Novel cancer therapies and their association with diabetes. J Mol Endocrinol 62:R187–R199
5. American Diabetes Association (2020) Diabetes technology: standards of medical care in diabetes-2020. Diabetes Care 43:S77-88